FDA Guidance on DSCSA Small Dispenser Exemption and Exemptions and Waivers for Other Trading Partners

In June 2024, the U.S. Food and Drug Administration (“FDA”) clarified, with respect to the Drug Supply Chain Security Act (“DSCSA”), that it will not extend the one-year stabilization period for the enhanced drug distribution requirements beyond November 27, 2024….
By: Epstein Becker & Green